These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Tumour promoter tert-butyl-hydroperoxide induces peroxynitrite formation in human erythrocytes.
    Author: Deliconstantinos G, Villiotou V, Stavrides JC.
    Journal: Anticancer Res; 1996; 16(5A):2969-79. PubMed ID: 8917415.
    Abstract:
    In the present study we demonstrated that human erythrocytes under normal conditions release small amounts of peroxynitrite (ONOO-) that can be considerably increased by the tumour promoter t-butylhydroperoxide (t-BHP), with a subsequent increase in lipid peroxidation and inhibition of Ca2+ pump ATPase activity. By causing oxidative stress in human erythrocytes with t-BHP, ONOO- release was increased approximately ten fold. N-monomethyl-L-arginine (L-NMMA) inhibited ONOO- release by approximately 90% while D-NMMA had no effect. The interaction of t-BHP with hemoglobin (Hb) and methemoglobin (MetHb) caused the production of superoxide (O2-) and hydrogen peroxide (H2O2). The differential direct effect of t-BHP on Hb and MetHb was investigated by taking their spectra in the presence or absence of cytochrome C. Erythrocyte membranes treated either with t-BHP or with ONOO- were subjected to oxidative stress with a subsequent increase in malondialdehyde (MDA) production and decrease in membrane fluidity, as estimated by the fluorescence polarization of 1,6,diphenyl-1,3,5-hexatriene (DPH). Ca2+ pump ATPase activity was decreased in t-BHP and/or ONOO-(-)treated erythrocytes, indicating that the subsequent intracellular calcium increase promoted ONOO- production by activating the Ca(2+)-calmodulin-dependent NO-synthase activity. These results suggest that hemoglobin oxidation by the tumour promoters play a key role in oxidative damage to erythrocytes and that the t-BHP/ Hb redox system could be a useful tool for investigating the tumour promoting efficacy of organic hydroperoxides.
    [Abstract] [Full Text] [Related] [New Search]